Bristol’s Melanoma Drug Combo Is A Cancer Breakthrough. Who Will Get It And Who Won’t?
A new cancer treatment from Bristol-Myers Squibb saved Gary McLaughlin’s life, but it also landed him in the hospital. Mclaughlin, 75, developed melanoma, the deadly skin cancer, just as he was retiring for real. He’d quit his job as a hospital administrator at 70, but spent two years helping his wife run […]

Vía Forbes Real Time